<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>GBIHealth | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-04T11:19:38+08:00</updated>
  <subtitle>GBI专注于中国市场，为药企、器械企业和其他服务提供商建立多元的市场情报解决方案组合。GBI的高附加值行业信息、新闻和数据服务能力帮助个人和组织做出以数据为驱动的决策，更高效地沟通。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>明儿进博会见！最后一波剧透：阿斯利康、辉瑞、赛诺菲、罗氏</title>
    <updated>2020-11-03T19:30:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/MavMH3dRi7pyeM8PqldDlw</id>
    <link href="https://mp.weixin.qq.com/s/MavMH3dRi7pyeM8PqldDlw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>财报解析 | 复星医药2020年Q3财报：收入221亿，利润增长20%</title>
    <updated>2020-11-03T19:30:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/_wK3L-ul195t38DQIKkcHg</id>
    <link href="https://mp.weixin.qq.com/s/_wK3L-ul195t38DQIKkcHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恩格列净：在华递交申请，化合物专利遇危机；罗氏药物纳入拟优先审评程序；药明巨诺昨日正式在港交所上市；一心堂澄清不实报道</title>
    <updated>2020-11-03T19:30:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/pNnn5dHuP7tnuzpW_wr8eA</id>
    <link href="https://mp.weixin.qq.com/s/pNnn5dHuP7tnuzpW_wr8eA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>财报解析 | 诺和诺德2020Q3财报，中国市场增长12%</title>
    <updated>2020-11-02T18:51:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/e7T2ERYg_Ne0T8972x37kQ</id>
    <link href="https://mp.weixin.qq.com/s/e7T2ERYg_Ne0T8972x37kQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>财报解析 | 安斯泰来2020Q3财报：全球下降5.4%，中国则增长0.5％</title>
    <updated>2020-11-02T18:51:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/rlsp8mI3tj0YNlVdgtvqcQ</id>
    <link href="https://mp.weixin.qq.com/s/rlsp8mI3tj0YNlVdgtvqcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞普强和迈兰合并后新公司中文名敲定为“晖致”；君实生物2020年Q3财报：前三季度收入增长91.78％；亚虹医药获批Ⅲ期临试</title>
    <updated>2020-11-02T18:51:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/Lf6DZIliIkxLDLy34sX6gQ</id>
    <link href="https://mp.weixin.qq.com/s/Lf6DZIliIkxLDLy34sX6gQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>财报解析 | 赛诺菲2020年Q3财报：中国前三季度下降11% ，第四季度有望恢复增长</title>
    <updated>2020-11-01T20:46:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/4EFkM89kSfuodWoatHlddQ</id>
    <link href="https://mp.weixin.qq.com/s/4EFkM89kSfuodWoatHlddQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>安斯泰来放弃开发TIGIT单抗；诺华CAR-T疗法中国临试入组首例受试者；赛诺菲戈谢病新药获批临床</title>
    <updated>2020-11-01T20:46:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/1u5YCQR4wk__qiZkyXiiHg</id>
    <link href="https://mp.weixin.qq.com/s/1u5YCQR4wk__qiZkyXiiHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 强生远端闭合双层网篮取栓器正式上市；迪谱诊断完成A轮融资</title>
    <updated>2020-11-01T20:46:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/CATlTzckYZbHgG85FRmmiA</id>
    <link href="https://mp.weixin.qq.com/s/CATlTzckYZbHgG85FRmmiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>倒计时5天！进博会剧透2 器械篇：美敦力、强生、珀金埃尔默、GE、BD</title>
    <updated>2020-10-29T21:45:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/IM5IbbH2cT9jCOPIenzXKg</id>
    <link href="https://mp.weixin.qq.com/s/IM5IbbH2cT9jCOPIenzXKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>财报解析 | 辉瑞2020年Q3财报：受带量采购影响，中国普强业绩下降21%</title>
    <updated>2020-10-29T21:45:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/glMfjdc1PHyrpIvYHCv6Gw</id>
    <link href="https://mp.weixin.qq.com/s/glMfjdc1PHyrpIvYHCv6Gw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基石药业豪掷3.6亿美元获一药物独家授权；罗氏泰圣奇联合治疗获批新适应症；百济神州与医院达成合作</title>
    <updated>2020-10-29T21:45:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/ArdxeF084bxkC29qaZN3DQ</id>
    <link href="https://mp.weixin.qq.com/s/ArdxeF084bxkC29qaZN3DQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>财报解析 | 诺华中国Q3增长13%，诺欣妥中国销售额激增102%！</title>
    <updated>2020-10-28T22:25:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/SFsXeBmrC198_VAZODXRyw</id>
    <link href="https://mp.weixin.qq.com/s/SFsXeBmrC198_VAZODXRyw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>财报解析 | 礼来中国Q3增长10%，达伯舒前三季度大卖2.06亿美元！</title>
    <updated>2020-10-28T22:25:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/upUVXbbc1vwgYqO47t6j9Q</id>
    <link href="https://mp.weixin.qq.com/s/upUVXbbc1vwgYqO47t6j9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>卫材与京东健康成立合资公司；荣昌生物全球发售拟募集37.1亿港元；诺诚健华、嘉和生物、中国生物制药最新药物动态</title>
    <updated>2020-10-28T22:25:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/xMEo47P7AwXrjeuNBhhtCQ</id>
    <link href="https://mp.weixin.qq.com/s/xMEo47P7AwXrjeuNBhhtCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>进博会又双叒来了，亮点抢先看！第一波儿剧透：默沙东、礼来、拜耳、BMS、BI</title>
    <updated>2020-10-27T23:47:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/3AdCMiD5yUzIXo2ZjjQwkA</id>
    <link href="https://mp.weixin.qq.com/s/3AdCMiD5yUzIXo2ZjjQwkA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基石药业达成13亿美元药物授权交易；礼来联合多家药店发布科普读物；先声药业登陆港交所</title>
    <updated>2020-10-27T23:47:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/EPJRNA5m4c171mlTfEp7bw</id>
    <link href="https://mp.weixin.qq.com/s/EPJRNA5m4c171mlTfEp7bw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 臻和科技完成超10亿元E轮融资；启明医疗TriGUARD3注册临床研究达主要安全性终点</title>
    <updated>2020-10-27T23:47:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/5D7ovCk_uNPTV4wcF31vfw</id>
    <link href="https://mp.weixin.qq.com/s/5D7ovCk_uNPTV4wcF31vfw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>外媒：美国药品降价，或将生物技术主导地位拱手让于中国？</title>
    <updated>2020-10-26T21:38:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/eCRu-_kqgRkskbTlk-bxWw</id>
    <link href="https://mp.weixin.qq.com/s/eCRu-_kqgRkskbTlk-bxWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>拜耳40亿美元收购Asklepios；GSK与爱康集团达成合作；富士胶片与国内公司合作销售法匹拉韦</title>
    <updated>2020-10-26T21:38:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/ObIyBhT9Ndh-_TFGv7Wcxg</id>
    <link href="https://mp.weixin.qq.com/s/ObIyBhT9Ndh-_TFGv7Wcxg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>